Overview

This trial is active, not recruiting.

Condition motivational interviewing
Treatment motivational interviewing
Sponsor Arnaud Gagneur
Collaborator Centre Hospitalier Universitaire de Québec, CHU de Québec
Start date June 2013
End date December 2015
Trial size 2719 participants
Trial identifier NCT02666872, 13-074, 27505

Summary

Vaccination greatly reduced mortality and morbidity from many preventable diseases. However, to avoid the resurgence of these diseases and the human drama associated, high vaccine coverage should be maintained in the population. Yet in Quebec, vaccine coverage (VC) in young children remains suboptimal, especially caused by a proportion of parents who are ambivalent about the safety and effectiveness of vaccines. In this context, the Provincial Immunization Committee developed in 2010 a Quebec's immunization promotion plan.

Therefore, our research team tested and validated across the Eastern Townships, a vaccination promotion concept by means of an educational intervention within maternities, based on motivational interviewing techniques. This intervention has not only significantly increased the intention of vaccination (+15%) within parents who had received the intervention but also increased their child vaccination coverage (+7.5% at 7 months). This is the purpose of the PROMOVAQ study (PROmotion of VAccination in Quebec) This research project evaluated the impact of an educational strategy based on motivational interviewing techniques within maternity ward on infants' VC. This strategy has been tested through a provincial study (Montreal, Quebec, Sherbrooke) including more than 2500 families.

At term, this research program will offer the Quebec's Health Ministry an optimal strategy for immunization awareness so that Quebec's children may grow healthy and thrive.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking open label
Primary purpose health services research
Arm
(Experimental)
An educational strategy based on motivational interviewing of approximately 15 minutes to promote vaccination, in maternity ward.
motivational interviewing
(No Intervention)
Parents in the control group only received a brochure about vaccines for infants. This brochure is given to all fathers and mothers giving birth to the CHUS, participating or not at our study.

Primary Outcomes

Measure
Vaccination status of the child at 7 months of age
time frame: 10 months

Secondary Outcomes

Measure
Vaccination status of the child at 3 and 5 months of age
time frame: 10 months
Vaccination status of the child at 13, 19 and 24 months of age
time frame: 24 months
Intention's parents to vaccination assessed by a questionnaire based on the Health Belief Model
time frame: Within the 20 minutes right before the intervention and within the first 20 minutes right after the intervention
Hesitancy 's parents to vaccination by a questionnaire based on the Opel's tool to measure vaccine hesitancy
time frame: Within the 20 minutes right before the intervention and within the first 20 minutes right after the intervention

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Parents of all infants born in each participating maternity hospitals - In Sherbrooke, inclusion limited to parents residing in the region of the Eastern Townships - In Québec, inclusion limited to parents residing in the National Capital region. Exclusion Criteria: - Minor parents - Parents who do not speak English or French - Any health condition of the child or the mother needing acute care. That is to say, if the child must be hospitalized in neonatology, or if the mother has an incompatible condition with an interview.

Additional Information

Official title Evaluation of a New Educational Strategy Promoting Vaccination in Maternity in Quebec Based on Motivational Interviewing Techniques: PROMOVAQ Study
Principal investigator Arnaud Gagneur, MD, Ph.D
Trial information was received from ClinicalTrials.gov and was last updated in January 2016.
Information provided to ClinicalTrials.gov by Université de Sherbrooke.